1 |
Alegre MM, Knowles MH, Robison RA, O'Neill KL (2013). Mechanics behind breast cancer prevention-focus on obesity, exercise and dietary fat. Asian Pac J Cancer Prev, 14, 2207-12.
과학기술학회마을
DOI
ScienceOn
|
2 |
Protani M, Coory M, Martin JH (2010). Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat, 123, 627-35.
DOI
|
3 |
Olmez OF, Evrensel T, Cubukcu E, et al (2013). Prognostic significance of human epidermal receptor (HER)- 3 immunohistochemical expression in patients with metastatic breast cancer. Asian Pac J Cancer Prev, 14, 4115-9.
과학기술학회마을
DOI
ScienceOn
|
4 |
Parekh N, Chandran U, Bandera EV (2012). Obesity in cancer survival. Annu Rev Nutr, 32, 311-42.
DOI
|
5 |
Petrelli JM, Calle EE, Rodriquez C, Thun MJ (2002). Body mass index, height and postemenapausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control, 13, 325-32.
DOI
|
6 |
Ryu SY, Kim CB, Nam CM, et al (2001). Is body mass index the prognostic factor in breast cancer? a meta-analysis. J Korean Med Sci, 16, 610-4.
과학기술학회마을
DOI
|
7 |
Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 283-98.
DOI
ScienceOn
|
8 |
Suleeporn S, Arkom C, Pattama P, et al (2013). Obesity, diet and physical inactivity and risk of breast cancer in Thai women. Asian Pac J Cancer Prev, 14, 7023-7.
과학기술학회마을
DOI
ScienceOn
|
9 |
Tanriverdi O, Meydan N, Barutca S (2014). Reconsideration of clinical and histopathological prognostic factors in breast cancer patients: a single center experience.. Asian Pac J Cancer Prev, 15, 807-12.
과학기술학회마을
DOI
|
10 |
Wu LZ, Han RQ, Zhou JY, et al (2014). Incidence and mortality of breast cancer in Jiangsu, China. Asian Pac J Cancer Prev, 15, 2727-32.
과학기술학회마을
DOI
|
11 |
Ewertz M, Jensen MB, Gunnarsdottir KA, et al (2011). Effect of obesity on prognosis after early stage breast cancer. J Clin Oncol, 29, 25-31.
DOI
ScienceOn
|
12 |
Berclaz G, Li S, Price KN, et al (2004). Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Ann Oncol, 15, 875-84.
DOI
ScienceOn
|
13 |
de Azambuja E, McCaskill-Stevens W, Francis P, et al (2010). The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial. Breast Cancer Res Treat, 119, 145-53.
DOI
|
14 |
Engin H, Bilir C, Tekin IO (2013). Prognostic significance of peripheral blood flow cytometry parameters in patients with non-metastatic breast cancer.. Asian Pac J Cancer Prev, 14, 7645-9.
과학기술학회마을
DOI
ScienceOn
|
15 |
Goodwin P (2013). Obesity and endocrine therapy: Host factors and breast cancer outcome. The Breast, 22, 44-7.
DOI
|
16 |
Griggs JJ, Sorbero ME, Lyman GH (2005). Undertreatment of obese women receiving breast cancer chemotherapy. Arch Intern Med, 165, 1267-73.
DOI
|
17 |
Malcolm AM, Yasantha A, Farhana B, et al (2009). Cancer epidemiology in South Asia - past, present and future. Asian Pac J Cancer Prev, 10, 49-67.
|
18 |
Taghavi A, Fazeli Z, Vahedi M, et al (2012). Incidence trend of breast cancer mortality in Iran. Asian Pac J Cancer Prev, 13, 367-70.
DOI
ScienceOn
|
19 |
Ademuyiwa F, Groman A, O'Connor T, et al (2011). Impact of body mass index on clinical outcomes in triple-negative breast cancer. Cancer, 117, 4132-40.
DOI
|
20 |
Klimant E, Glurich I, Mukesh B, Onitilo A (2011). Blood type, hormone receptor status, HER2/neu status, and survival in breast cancer: A retrospective study exploring relationships in a phenotypically well-defined cohort. Clin Med & Res, 9, 111-8.
DOI
|
21 |
Sestak I, Distler W, Forbes JF, et al (2010). Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial. J Clin Oncol, 28, 3411-5.
DOI
|
22 |
Ladoire S, Dalban C, Roche H, et al (2014). Effect of obesity on disease-free and overall survival in node-positive breast cancer patients in a large French population: A pooled analysis of two randomised trials. Eur J Cancer, 50, 506-16.
DOI
|